Product Description: EAPB0202 is an imidazolium and quinoxaline derivative. EAPB0202 shows significant cytotoxicity to A375 human melanoma cell line with an IC50 of 2.35 μM. EAPB0202 can be used in the study of cancer[1].
Formula: C18H16N4
References: [1]Moarbess G, et al. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorg Med Chem. 2008 Jul 1;16(13):6601-10.
CAS Number: 681284-82-2
Molecular Weight: 288.35
Research Area: Cancer
Target: Drug Derivative